Furthermore, it addresses the FDA’s communications Together with the applicant, the retention of data that aid the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of the SE report back to a completely new applicant and electronic submission with th